These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 141140)

  • 1. Why do HLA-nonidentical renal allografts survive 10 years or more?
    Thomas J; Thomas F; Lee HM
    Transplant Proc; 1977 Mar; 9(1):85-9. PubMed ID: 141140
    [No Abstract]   [Full Text] [Related]  

  • 2. The new serology of histocompatibility testing and its significance in human renal transplantation.
    Braun WE
    Urol Clin North Am; 1976 Oct; 3(3):503-25. PubMed ID: 136083
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections.
    Warren RP; Storb R; Weiden PL; Mickelson EM; Thomas ED
    Transplantation; 1976 Dec; 22(6):631-5. PubMed ID: 137561
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term follow-up of renal transplant recipients using immunologic monitoring.
    Miller J; Kyriakides G; Flaa C
    Transplant Proc; 1979 Mar; 11(1):360-3. PubMed ID: 156425
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation.
    Albrechtsen D; Arnesen E; Solheim BG; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):743-7. PubMed ID: 156432
    [No Abstract]   [Full Text] [Related]  

  • 6. Humoral factors. Immunologic enhancement.
    Batchelor JR; Welsh KI; Burgos H
    Transplant Proc; 1977 Mar; 9(1):931-6. PubMed ID: 141143
    [No Abstract]   [Full Text] [Related]  

  • 7. [HLA-compatibility testing in kidney transplantation--past, present and future].
    van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Lansbergen Q; Cohen B
    Chirurg; 1980 May; 51(5):257-62. PubMed ID: 6447582
    [No Abstract]   [Full Text] [Related]  

  • 8. [Incidence of anti-HL-A antibodies in patients under dialysis and in a transplantation program in relation to rejection].
    Erbenová E; Erben J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1976; 19(3):303-9. PubMed ID: 801077
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mixed lymphocyte culture and HLA typing in a family with a recombination between loci of the major HLA histocompatibility system].
    Genetet N; Genetet B; Fauchet R; Cartier F; Launois B
    C R Seances Soc Biol Fil; 1976 Oct; 170(3):650-4. PubMed ID: 135628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-specific blood transfusions in HLA-D-disparate one-haplotype-related allografts.
    Cochrum KC; Hanes D; Potter D; Vincenti F; Amend W; Feduska N; Perkins H; Salvatierra O
    Transplant Proc; 1979 Dec; 11(4):1903-7. PubMed ID: 161102
    [No Abstract]   [Full Text] [Related]  

  • 11. Multifactorial analysis of factors influencing graft survival in recipients of living related renal allografts.
    Green WF; Niblack GD; Johnson HK; Richie RE; Tallent MB; MacDonnell R; Turner B; Harbison P; Ganaway S
    Transplant Proc; 1982 Jun; 14(2):282-6. PubMed ID: 6214057
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA frequencies among rejectors and low responders to kidney allografts.
    Opelz G; Terasaki PI
    Transplantation; 1976 Apr; 21(4):361-3. PubMed ID: 59986
    [No Abstract]   [Full Text] [Related]  

  • 13. Tissue typing in renal transplantation: the impact of cyclosporine.
    Benvenisty AI; Cohen DJ; Hardy MA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):19-28. PubMed ID: 2938321
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival.
    Cochrum K; Hanes D; Van Speybroeck J; Perkins H; Ferrone S; Indeveri F; Amend W; Vincenti F; Feduska N; Salvatierra O
    Transplant Proc; 1979 Mar; 11(1):404-10. PubMed ID: 156426
    [No Abstract]   [Full Text] [Related]  

  • 15. Major and minor histocompatibility systems in man and their importance in bone marrow transplantation.
    van Rood JJ; van Leeuwen A
    Transplant Proc; 1976 Sep; 8(3):429-36. PubMed ID: 62433
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of pretreatment with donor blood on renal allograft survival in dogs stratified by DLA match and MLC reactivity.
    Sutherland DE; Lum CT; Payne WD; Najarian JS
    Transplant Proc; 1979 Mar; 11(1):160-6. PubMed ID: 156422
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of immunosuppressive therapy, HLA matching and donor age on long term cadaveric pediatric renal allograft survival.
    Groenewoud AF; Persijn GG; D'Amaro J; de Lange P; Cohen B
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1683-4. PubMed ID: 2652551
    [No Abstract]   [Full Text] [Related]  

  • 18. The correlation of tissue typing, mixed lymphocyte culture, and related donor renal allograft survival.
    Cerilli J; Newhouse YG; Williams MA
    Transplant Proc; 1978 Dec; 10(4):953-4. PubMed ID: 153622
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship of mixed lymphocyte culture response, HL-A histocompatibility antigens, and renal transplantation.
    Thompson JS; Flink RJ; Caldwell JL; Severson CD; Bonney WW
    Transplant Proc; 1973 Dec; 5(4):1763-9. PubMed ID: 4130081
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of matching for RhLA (SD) antigens and of mixed lymphocyte reactivity on allograft survival in unrelated rhesus monkeys.
    van Es AA; Marquet RL; van Vreeswijk W; Tank B; Balner H
    Transplant Proc; 1977 Mar; 9(1):257-60. PubMed ID: 141128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.